Human Milk Oligosaccharides Modulating Inflammation in Infants, Adults, and Older Individuals—From Concepts to Applications
Advances in Nutrition · 2025
DOI: 10.1016/j.advnut.2025.100433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Nutrition, 2025. Verfasst von Robert Häsler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, University Kiel, Kiel, Germany. Electronic address: rhaesler@dermatology.uni-kiel.de. Hauptthemen laut MEDLINE: Oligosaccharides, Milk, Human, Prebiotics, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Firmenich, Christian Albrechts Universität zu Kiel.
Abstract (Originalsprache)
The increasing global prevalence of inflammatory diseases, such as ulcerative colitis and irritable bowel syndrome, represents a challenging task for healthcare systems. Several approaches to disease management target the intestinal microbiome, which plays a key role in health and disease. One promising approach is modulating the microbiome using human milk oligosaccharides (HMOs). Originating from human milk, HMOs are indigestible carbohydrates that act in a host-optimized prebiotic fashion by providing an energy source for health-promoting intestinal bacteria and exhibiting systemic effects. Commercial products supporting infant health and development have been the primary fields of HMO application. Advancements in the large-scale production of HMOs through bioengineering and precision fermentation have led to evaluation of their potential for managing inflammatory diseases. Several in vitro studies and observations on model systems have been clinically validated in infants, resulting in a large body of evidence supporting the safety and efficacy of HMOs in inflammatory disorders. Although novel approaches seek to explore interventions in adults, the primary goal for the future is to provide cost-efficient, safe, and reliable healthcare compounds across all age groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergology, University Kiel, Kiel, Germany. Electronic address: rhaesler@dermatology.uni-kiel.de.
- Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland; dsm-firmenich, Glycom A/S, Hørsholm, Denmark.
- dsm-firmenich, Health, Nutrition & Care, Kaiseraugst, Switzerland.
- dsm-firmenich, Glycom A/S, Hørsholm, Denmark.
Förderung
- Firmenich
- Christian Albrechts Universität zu Kiel
Zitieren
APA
Häsler, R., Mikš, M. H., Bajic, D., Soyyilmaz, B., Bendik, I., van Buul, V. J., Steinert, R. E., & Rehman, A. (2025). Human Milk Oligosaccharides Modulating Inflammation in Infants, Adults, and Older Individuals—From Concepts to Applications. Advances in Nutrition. https://doi.org/10.1016/j.advnut.2025.100433
Vancouver
Häsler R, Mikš MH, Bajic D, Soyyilmaz B, Bendik I, van Buul VJ, et al. Human Milk Oligosaccharides Modulating Inflammation in Infants, Adults, and Older Individuals—From Concepts to Applications. Advances in Nutrition. 2025. doi:10.1016/j.advnut.2025.100433
BibTeX
@article{Hsler2025,
author = {Häsler, Robert and Mikš, Marta Hanna and Bajic, Danica and Soyyilmaz, Buket and Bendik, Igor and van Buul, Vincent J and Steinert, Robert E and Rehman, Ateequr},
title = {Human Milk Oligosaccharides Modulating Inflammation in Infants, Adults, and Older Individuals—From Concepts to Applications},
journal = {Advances in Nutrition},
year = {2025},
doi = {10.1016/j.advnut.2025.100433}
}
EUVIMED